Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 28Genitourinary 13Breast 12Thoracic 8Other solid neoplasm 8Dermatologic 5Sarcoma 4Plasma cell 4Other hematologic neoplasm 4Tumor-Agnostic 3Gynecologic 3CNS 3Myeloid 2Lymphoid 2Other 1Head & Neck 1

Conditions

Recurrence 1Neoplasm Metastasis 1Nasopharyngeal Carcinoma 1

Interventions

Cisplatin 631Radiotherapy 339pembrolizumab 329Cetuximab 284Docetaxel 226Radiotherapy, Intensity-Modulated 221Fluorouracil 199Carboplatin 198Paclitaxel 161Nivolumab 145Gemcitabine 125Magnetic Resonance Spectroscopy 99Radiation 91Drug Therapy 86Capecitabine 77toripalimab 75Surveys and Questionnaires 73Surgical Procedures, Operative 72Biopsy 62durvalumab 61Chemoradiotherapy 52Blood Specimen Collection 52Cyclophosphamide 50Specimen Handling 47camrelizumab 46Radiosurgery 46Erlotinib Hydrochloride 46Standard of Care 44130-nm albumin-bound paclitaxel 44tislelizumab 42

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hydroxychloroquine × Head & Neck × Clear all
NCT06389201 2025-02-18

Pretreatment With HCQ Before Radiotherapy and Chemotherapy in Advanced NPC Patients

Affiliated Hospital of Nantong University

Phase NA Recruiting
30 enrolled
Head & Neck

Nasopharyngeal Carcinoma, Neoplasm Metastasis, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡